These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 1341052)

  • 1. Multimeric structures influence the binding activity of bHLH muscle regulatory factors.
    Wright WE; Catala F; Farmer K
    Symp Soc Exp Biol; 1992; 46():79-87. PubMed ID: 1341052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative multimeric structures affect myogenin DNA binding activity.
    Farmer K; Catala F; Wright WE
    J Biol Chem; 1992 Mar; 267(8):5631-6. PubMed ID: 1312093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of muscle-specific transcription by myogenic helix-loop-helix proteins.
    Olson E
    Symp Soc Exp Biol; 1992; 46():331-41. PubMed ID: 1341046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the myogenic determination factor myogenin with E12 and a DNA target: mechanism and kinetics.
    Spinner DS; Liu S; Wang SW; Schmidt J
    J Mol Biol; 2002 Mar; 317(3):431-45. PubMed ID: 11922675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MyoD-E12 heterodimers and MyoD-MyoD homodimers are equally stable.
    Maleki SJ; Royer CA; Hurlburt BK
    Biochemistry; 1997 Jun; 36(22):6762-7. PubMed ID: 9184158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antimyogenin antibodies define epitopes outside the bHLH domain where binding interferes with protein-protein and protein-DNA interactions.
    Wright WE; Dac-Korytko I; Farmer K
    Dev Genet; 1996; 19(2):131-8. PubMed ID: 8900045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the DNA-binding properties of MyoD, myogenin, and E12 by fluorescence anisotropy.
    Maleki SJ; Royer CA; Hurlburt BK
    Biochemistry; 2002 Sep; 41(35):10888-94. PubMed ID: 12196028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MyoD and achaete-scute: 4-5 amino acids distinguishes myogenesis from neurogenesis.
    Davis RL; Cheng PF; Lassar AB; Thayer M; Tapscott S; Weintraub H
    Princess Takamatsu Symp; 1989; 20():267-78. PubMed ID: 2562185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.
    Valdez MR; Richardson JA; Klein WH; Olson EN
    Dev Biol; 2000 Mar; 219(2):287-98. PubMed ID: 10694423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation of the myogenin gene by MEF2-mediated recruitment of myf5 is inhibited by adenovirus E1A protein.
    Johanson M; Meents H; Ragge K; Buchberger A; Arnold HH; Sandmöller A
    Biochem Biophys Res Commun; 1999 Nov; 265(1):222-32. PubMed ID: 10548518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The basic helix-loop-helix domain of the E47 transcription factor requires other protein regions for full DNA binding activity.
    Lu J; Sloan SR
    Biochem Biophys Res Commun; 2002 Feb; 290(5):1521-8. PubMed ID: 11820794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level expression and purification of MyoD, myogenin, and E12.
    Maleki SJ; Hurlburt BK
    Protein Expr Purif; 1997 Feb; 9(1):91-9. PubMed ID: 9116507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myogenin's functions do not overlap with those of MyoD or Myf-5 during mouse embryogenesis.
    Rawls A; Morris JH; Rudnicki M; Braun T; Arnold HH; Klein WH; Olson EN
    Dev Biol; 1995 Nov; 172(1):37-50. PubMed ID: 7589813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
    Grasberger H; Ye H; Mashima H; Bell GI
    Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target gene selectivity of the myogenic basic helix-loop-helix transcription factor myogenin in embryonic muscle.
    Davie JK; Cho JH; Meadows E; Flynn JM; Knapp JR; Klein WH
    Dev Biol; 2007 Nov; 311(2):650-64. PubMed ID: 17904117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition of myogenic specificity through replacement of one amino acid of MASH-1 and introduction of an additional alpha-helical turn.
    Dezan C; Meierhans D; Künne AG; Allemann RK
    Biol Chem; 1999 Jun; 380(6):705-10. PubMed ID: 10430036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of MRF4, myogenin, and E12 oligomer complexes by chemical cross-linking and two-dimensional gel electrophoresis.
    Lin H; Konieczny SF
    J Biol Chem; 1992 Mar; 267(7):4773-80. PubMed ID: 1311321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential binding of MyoD-E12 versus myogenin-E12 to the murine sarcoma virus enhancer in vitro.
    Czernik PJ; Peterson CA; Hurlburt BK
    J Biol Chem; 1996 Apr; 271(15):9141-9. PubMed ID: 8621566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myogenin resides in the nucleus and acquires high affinity for a conserved enhancer element on heterodimerization.
    Brennan TJ; Olson EN
    Genes Dev; 1990 Apr; 4(4):582-95. PubMed ID: 2163343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta represses the actions of myogenin through a mechanism independent of DNA binding.
    Brennan TJ; Edmondson DG; Li L; Olson EN
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3822-6. PubMed ID: 1850837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.